Early Biomarkers of Clinical–Diffusion Mismatch in Acute Ischemic Stroke | Zendy

Manuel RodríguezYáñez | Zendy; Tomás Sobrino | Zendy; Susana Arias | Zendy; Fernando Vázquez-Herrero | Zendy; David Brea | Zendy; Miguel Blanco | Zendy; Rogelio Leira | Zendy; Mar Castellanos | Zendy; Joaquı́n Serena | Zendy; José Vivancos | Zendy; Antonio Dávalos | Zendy; José Castillo | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Early Biomarkers of Clinical–Diffusion Mismatch in Acute Ischemic Stroke

Author(s) -

Manuel RodríguezYáñez,

Tomás Sobrino,

Susana Arias,

Fernando Vázquez-Herrero,

David Brea,

Miguel Blanco,

Rogelio Leira,

Mar Castellanos,

Joaquı́n Serena,

José Vivancos,

Antonio Dávalos,

José Castillo

Publication year - 2011

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.111.614503

Subject(s) - medicine , stroke (engine) , ischemic stroke , acute stroke , clinical neurology , cardiology , ischemia , neuroscience , tissue plasminogen activator , mechanical engineering , engineering , biology

Clinical-diffusion mismatch (CDM; National Institutes of Health Stroke Scale score≥8 and diffusion-weighted imaging lesion volume<25 mL) has been suggested as a surrogate of ischemic brain at risk of infarction and might be used to recognize salvageable ischemic tissue. Our aim was to identify early biomarkers associated with the presence of CDM.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research